Designer phospholipid capping ligands for soft metal halide nanocrystals.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 38109940.
- Also identified by DOI 10.1038/s41586-023-06932-6 and PMC identifier 10866715.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
The success of colloidal semiconductor nanocrystals (NCs) in science and optoelectronics is inextricable from their surfaces. The functionalization of lead halide perovskite NCs<sup>1-5</sup> poses a formidable challenge because of their structural lability, unlike the well-established covalent ligand capping of conventional semiconductor NCs<sup>6,7</sup>. We posited that the vast and facile molecular engineering of phospholipids as zwitterionic surfactants can deliver highly customized surface chemistries for metal halide NCs. Molecular dynamics simulations implied that ligand-NC surface affinity is primarily governed by the structure of the zwitterionic head group, particularly by the geometric fitness of the anionic and cationic moieties into the surface lattice sites, as corroborated by the nuclear magnetic resonance and Fourier-transform infrared spectroscopy data. Lattice-matched primary-ammonium phospholipids enhance the structural and colloidal integrity of hybrid organic-inorganic lead halide perovskites (FAPbBr<sub>3</sub> and MAPbBr<sub>3</sub> (FA, formamidinium; MA, methylammonium)) and lead-free metal halide NCs. The molecular structure of the organic ligand tail governs the long-term colloidal stability and compatibility with solvents of diverse polarity, from hydrocarbons to acetone and alcohols. These NCs exhibit photoluminescence quantum yield of more than 96% in solution and solids and minimal photoluminescence intermittency at the single particle level with an average ON fraction as high as 94%, as well as bright and high-purity (about 95%) single-photon emission.
Medical subject headings
- Ligands
- Metal Nanoparticles
- Quantum Dots
- Drug Design